Psilocybe Mexicana Mushrooms cultivated by a resident of Washington, DC. Researchers study psychedelics such as psilocybin to treat depression, SSPT and other disorders. But researchers still don’t know exactly why they work.
Photo by Jahi Chikwendiu / The Washington Post via Getty Images
hide
tilting legend
Photo by Jahi Chikwendiu / The Washington Post via Getty Images
Psilocybe Mexicana Mushrooms cultivated by a resident of Washington, DC. Researchers study psychedelics such as psilocybin to treat depression, SSPT and other disorders. But researchers still don’t know exactly why they work.
Photo by Jahi Chikwendiu / The Washington Post via Getty Images
Researchers study psychedelics as a possible treatment for conditions such as depression, SSPT and substance consumption disorders. But they don’t know exactly how these drugs work.
Obtaining the answer to this question is particularly difficult when people often take psychedelics such as LSD and psilocybin for their brand “trips”.
Some researchers believe that these psychoactive spiritual effects are a large part of the reason why patients could benefit from psychedelic drugs. Other researchers think that the power of these drugs can reside in how they change chemistry or brain structure.
This week on Short waveWe are talking to researchers about how they try to unravel these triple factors from psychedelic medicine … and why the answer could help direct the future of industry.
Catch the rest of this series on psychedelics and related drugs this week by following us on Spotify And Apple podcasts.
Do you have any other questions about psychedelics and the brain? Let us know by e-mail shortwave@npr.org!
Listen to each episode of Short Wave Sponsor-Free and support our work at NPR by registering for Short Wave + plus.npr.org/Shortwave.
This episode was produced by Hannah Chinn. He was edited by Geoff Brumfiel and Rebecca Ramirez. Tyler Jones checked the facts. Kwesi Lee was the audio engineer.